From Virtual Molecules to Clinical Trials: How AI Is Reshaping Preclinical Drug Discovery.
Where this comes from
- Record sourced from PubMed, PMID 42212863.
- Also identified by DOI 10.2196/101366.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Pharmaceutical development is typically a long and arduous process, but advances in artificial intelligence may help streamline each stage of this pipeline. In this News and Perspectives article, JMIR Correspondent Benedette Cuffari reports on recent innovations and their potential implications for drug discovery.
Medical subject headings
- Artificial Intelligence
- Clinical Trials as Topic
- Drug Discovery